{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:06:24Z","timestamp":1768413984088,"version":"3.49.0"},"reference-count":13,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["eJHaem"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1002\/jha2.946","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:44:40Z","timestamp":1721781880000},"page":"887-891","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Carfilzomib use in patients with relapsed\/refractory multiple myeloma in France: A national retrospective cohort study"],"prefix":"10.1002","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3749-5161","authenticated-orcid":false,"given":"Cyrille","family":"Hulin","sequence":"first","affiliation":[{"name":"Hematology unit Hospital Center University De Bordeaux  Bordeaux France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-1307","authenticated-orcid":false,"given":"Nadia","family":"Quignot","sequence":"additional","affiliation":[{"name":"Certara Evidence & Access  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Certara Evidence & Access  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakima","family":"Mechiche","sequence":"additional","affiliation":[{"name":"Amgen SAS  Boulogne\u2010Billancourt France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00eblle","family":"D\u00e9sam\u00e9ricq","sequence":"additional","affiliation":[{"name":"Amgen SAS  Boulogne\u2010Billancourt France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"e_1_2_1_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411321"},{"key":"e_1_2_1_10_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0583-7"},{"key":"e_1_2_1_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30734-0"},{"key":"e_1_2_1_10_5_1","unstructured":"European Medicines Agency.CHMP summary of positive opinion for Kyprolis.European Medicines Agency;2015. Accessed September 24 2015.https:\/\/www.ema.europa.eu\/documents\/smop\u2010initial\/chmp\u2010summary\u2010positive\u2010opinion\u2010kyprolis_en.pdf"},{"key":"e_1_2_1_10_6_1","unstructured":"European Medicines Agency.CHMP post\u2010authorisation summary of positive opinion for Kyprolis.European Medicines Agency;2016. Accessed May 26 2016.https:\/\/www.ema.europa.eu\/documents\/smop\/chmp\u2010post\u2010authorisation\u2010summary\u2010positive\u2010opinion\u2010kyprolis_en.pdf"},{"key":"e_1_2_1_10_7_1","unstructured":"European Medicines Agency.CHMP post\u2010authorisation summary of positive opinion for Kyprolis.European Medicines Agency;2020. Accessed November 12 2020.https:\/\/www.ema.europa.eu\/documents\/smop\/chmp\u2010post\u2010authorisation\u2010summary\u2010positive\u2010opinion\u2010kyprolis\u2010ii\u201045_en.pdf"},{"key":"e_1_2_1_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.595"},{"key":"e_1_2_1_10_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215311"},{"key":"e_1_2_1_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04522-y"},{"key":"e_1_2_1_10_11_1","unstructured":"Amgen Europe BV.Summary of product characteristics Kyprolis.European Medicines Agency;2020. Accessed January 12 2023.https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/kyprolis\u2010epar\u2010product\u2010information_en.pdf"},{"key":"e_1_2_1_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.559"},{"key":"e_1_2_1_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0141-0"},{"key":"e_1_2_1_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30756-7"}],"container-title":["eJHaem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jha2.946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T02:15:34Z","timestamp":1760408134000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jha2.946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1002\/jha2.946"],"URL":"https:\/\/doi.org\/10.1002\/jha2.946","archive":["Portico"],"relation":{},"ISSN":["2688-6146","2688-6146"],"issn-type":[{"value":"2688-6146","type":"print"},{"value":"2688-6146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"2023-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}